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Endoplasmic reticulum (ER) stress is observed in
many human diseases, often associated with inflam-
mation. ER stress can trigger inflammation through
nucleotide-binding domain and leucine-rich repeat
containing (NLRP3) inflammasome, which might
stimulate inflammasome formation by association
with damaged mitochondria. How ER stress triggers
mitochondrial dysfunction and inflammasome acti-
vation is ill defined. Here we have used an infection
model to show that the IRE1a ER stress sensor reg-
ulates regulated mitochondrial dysfunction through
an NLRP3-mediated feed-forward loop, indepen-
dently of ASC. IRE1a activation increased mitochon-
drial reactive oxygen species, promoting NLRP3
association with mitochondria. NLRP3 was required
for ER stress-induced cleavage of caspase-2 and
the pro-apoptotic factor, Bid, leading to subsequent
release of mitochondrial contents. Caspase-2 and
Bid were necessary for activation of the canonical
inflammasome by infection-associated or general
ER stress. These data identify an NLRP3-caspase-
2-dependent mechanism that relays ER stress to
the mitochondria to promote inflammation, inte-
grating cellular stress and innate immunity.
INTRODUCTION
Cellular stress provokes release of molecular danger signals that
stimulate inflammatory signaling (Kono and Rock, 2008; Zhang
et al., 2013), but the mechanisms linking stress with release of
danger-associated molecular patterns (DAMPs) are not fully
defined. Such mechanisms are relevant to human health as
molecular stress and inflammation increase with age and are
associated with many acute and chronic diseases (Brown and
Naidoo, 2012; Davis et al., 2011; Hao et al., 2013; Tan et al.,Im2013). Mitochondria can act as platforms to nucleate signaling
by large molecular complexes, like the nucleotide-binding
domain and leucine-rich repeat containing (NLRP3) inflamma-
some, and drive inflammation through release of mitochondrial
DAMPs in response to diverse stressors (Subramanian et al.,
2013). How such distinct stressors as infection, glucose depriva-
tion, oxidative stress, or disruption of calcium homeostasis
trigger these inflammatory events is unclear. The endoplasmic
reticulum (ER) is a large endomembrane compartment that is
highly sensitive to perturbation and is central to the function of
many organelle networks, suggesting that ER might act as a
relay station between stressors and mitochondria, linking stress
and inflammatory signaling.
Three ER-resident unfolded protein sensors, IRE1a (IRE1),
ATF6, and PERK control the ER stress response, an adaptive
program that defines the fate of the stressed cell (Hetz, 2012).
Toll-like receptors (TLR), which primarily recognize microbial
ligands like lipopolysaccharide (LPS), selectively stimulate IRE1
(Martinon et al., 2010), and LPS-primed macrophages react to
ER stressors by activating the NLRP3 inflammasome (Menu
et al., 2012). Microbial infection is a useful model for investigating
ER stress and inflammation because infection is often associ-
ated with ER stress, and animals deficient in components of
the IRE1 signaling pathway are more susceptible to bacterial
infection than controls (Bischof et al., 2008; Martinon et al.,
2010; Pillich et al., 2012; Seimon et al., 2010). NLRP3-deficient
animals exhibit increased susceptibility and decreased survival
during infection by some microbial pathogens (von Moltke
et al., 2013). Brucella abortus strain RB51 is an attenuated bac-
terial vaccine strain that infects macrophages, causes ER stress,
and provokes a robust immune response without the complex
effects of intracellular replication (Li and He, 2012). We therefore
usedRB51 as a probe to elucidate ER stress-dependent immune
signaling. Virulent B. abortusmediates inflammasome activation
through NLRP3 (Gomes et al., 2013), suggesting that B. abortus
strains could be appropriate for studying the interplay between
ER stress and NLRP3-dependent immune signaling (Davis
et al., 2011). Notably, NLRP3 in resting cells is associated with
ER, but upon stimulation moves to ER-mitochondrial junctions
(Zhou et al., 2011). These data led us to hypothesize that uponmunity 43, 451–462, September 15, 2015 ª2015 Elsevier Inc. 451
infection, ER stress sensors could modulate NLRP3-dependent
crosstalk between ER andmitochondria by an as yet unidentified
mechanism, leading to inflammasome activation.
RESULTS
RB51-Induced Inflammasome Activation Requires IRE1
and TXNIP
TLR ligands (e.g., LPS) activate IRE1, but not ATF6 or PERK,
activating transcription of proinflammatory cytokines (Martinon
et al., 2010). To determine whether IRE1 was stimulated during
RB51 infection, we investigated splicing of Xbp1 transcript, a
direct target of the endonuclease domain of activated IRE1
(Hetz, 2012; Sidrauski and Walter, 1997). Tunicamycin (TM),
an inhibitor of protein glycosylation (Hetz, 2012; Olden et al.,
1978; Zeng and Elbein, 1995), served as a positive control
for ER stress assays. Robust splicing of Xbp1 was seen in
TM-treated bone-marrow-derived macrophages (BMDM) and
RB51-infected BMDM at 8 hr post-infection (pi) (Figure 1A). ER
stress signaling can lead to cell death in some contexts (Lerner
et al., 2012; Oslowski et al., 2012), so we measured cell death
by release of lactate dehydrogenase, and found that the majority
of infected cells were viable by 8 hr pi (Figure S1A). Thus, infec-
tion by RB51 stimulated IRE1 activation, as previously observed
for other microbial ligands (Martinon et al., 2010).
Recent studies revealed that ER stress can drive inflamma-
some activation (Lerner et al., 2012). RB51 stimulated robust
interleukin-1b (IL-1b) production at both low and high multiplicity
of infection (MOI), and at high MOI was comparable to the pos-
itive control LPS+ATP treatment (Figure S1B). We therefore
tested whether ER stress was required for RB51-induced IL-1b
production. Inhibition of IRE1 with 4m8C (Cross et al., 2012) in
RB51-infected BMDM led to decreased Xbp1 splicing and cas-
pase-1 cleavage (Figure S1C and Figure 1B). Treatment with
tauroursodeoxycholic acid (TUDCA), a molecular chaperone
that alleviates ER stress, or 4m8C, resulted in less IL-1b pro-
duction in RB51-infected BMDM, but not BMDM treated with
LPS+ATP, our positive control for inflammasome activation (Fig-
ure 1C). Neither TUDCA nor 4m8C decreased bacterial uptake
(Figure S1D). IRE1 inhibition did not affect Il1b transcription, sug-
gesting that IRE1 signaling was not required for priming (Fig-
ure 1D). IRE1 inhibition also had no effect on LPS+ATP-induced
caspase-1 cleavage and IL-1b production. These data suggest
that unlike RB51, LPS+ATP does not rely on ER stress to induce
IL-1b production. Like IRE1 inhibition, silencing of Ern1, the gene
that encodes IRE1 (Figure S1E and F), decreased Xbp1 splicing,
caspase-1 cleavage and IL-1b production in RB51-infected
BMDM. To determine whether IRE1 modulates inflammation
in vivo, we treated C57BL/6 mice with either vehicle control or
4m8C, and infected animals intraperitoneally with 108 CFU of
RB51. Consistent with our in vitro findings, 4m8C-treated mice
showed significantly less serum IL-1b and increased bacterial
burden (Figure 1E and Figure S1G). These data point to IRE1
as an important regulator of ER stress-induced inflammasome
activation during infection.
Previous studies identified multiple targets for the IRE1 endo-
nuclease, including Xbp1 and miR-17, a negative regulator of
thioredoxin-interacting protein (TXNIP) translation (Lerner et al.,
2012; Yoshida et al., 2001). The XBP1 transcription factor selec-452 Immunity 43, 451–462, September 15, 2015 ª2015 Elsevier Inc.tively enhances transcription of pro-inflammatory cytokine
genes (Martinon et al., 2010). IRE1-dependent miR-17 degrada-
tion increases TXNIP protein, which shuttles tomitochondria and
binds thioredoxin-2, raising concentrations of mitochondrial
reactive oxygen species (ROS) (Lerner et al., 2012). To assess
whether XBP1 or TXNIP controls IRE1-driven IL-1b production,
we transfected BMDM with Xbp1 or Txnip specific siRNA, in-
fected with RB51 and measured supernatant IL-1b. Transient
silencing of Xbp1 had no effect on RB51-induced IL-1b produc-
tion (Figure 1F), while silencing of Txnip led to reductions in IL-1b
and ROS in infected BMDM (Figures 1G and 1H). These data
indicate that during infection-induced ER stress, IRE1 acts
through TXNIP to induce IL-1b production.
ER Stress-Induced Mitochondrial Dysfunction Aids in
Inflammasome Activation
ER stress drives mitochondria to release mitochondrial-derived
damage associated molecular patterns (mtDAMPs), which can
activate the inflammasome (Iyer et al., 2013; Nakahira et al.,
2011; Zhou et al., 2011). Previous studies have shown that
TXNIP shuttling to mitochondria increases mtROS (Saxena
et al., 2010). We observed increased ROS over time in RB51-in-
fected BMDM, a phenotype dependent upon both IRE1 and
TXNIP (Figure 1H). To determine whether mtROS was required
for IRE1-induced IL-1b production, we infected BMDM derived
from transgenic mice that express a mitochondrial-targeted
catalase (mCAT) (Lee et al., 2010). Both ROS and IL-1b
decreased in infected mCAT BMDM compared to infected WT
BMDM (Figures 2A and 2B). The decreased ROS in mCAT
BMDM had no effect on LPS+ATP-induced IL-1b production,
consistent with previous work showing that mitochondrial func-
tion is not essential for activation of the NLRP3 inflammasome
(Mun˜oz-Planillo et al., 2013). Since we observed increased
ROS upon RB51 infection, possibly indicating mitochondrial
dysfunction, we infected BMDM with RB51 and measured
cytochrome c and mtDNA release. TM-treated and RB51-in-
fected macrophages released mtDNA and cytochrome c into
the cytosol, a process blocked by IRE1 inhibition or silencing
(Figure 2C and Figures S2A and S2B). Since the presence of
transfected mtDNA in the cytosol can stimulate IL-1b pro-
duction (Nakahira et al., 2011; Shimada et al., 2012), we inves-
tigated whether release of mitochondrial components during
RB51 infection contributed to IL-1b production by treating
BMDM with cyclosporin A (CsA), which prevents opening of
the mitochondrial permeability transition pore (Handschu-
macher et al., 1984). We infected BMDM with RB51 with or
without CsA, and measured IL-1b production by ELISA. CsA
treatment significantly decreased IL-1b in RB51-infected mac-
rophages, even though bacterial uptake was unaffected (Fig-
ures 2D and S2C). In contrast, CsA treatment did not affect
IL-1b production in LPS+ATP treated BMDM, indicating that
our specific LPS+ATP treatment protocol induces IL-1b pro-
duction independently of mitochondrial damage (Figure 2D).
However, a different LPS+ATP treatment protocol led to mark-
edly higher amounts of mtDNA released into the cytosol (Fig-
ure S2D), suggesting that involvement of the mitochondria in
inflammasome activation by the classical activator, LPS+ATP,
might depend on the extent or duration of cellular stress.
Taken together, these data show that RB51-induced ER stress
Figure 1. IRE1 Modulates Infection-Induced Inflammasome Activation via TXNIP
(A) Xbp1 splicing, a marker of IRE1 activation, in RB51-infected BMDM. qRT-PCR samples were treated with PstI to distinguish between spliced (184 bp) and
unspliced variants (119 bp following PstI digestion).
(B) Caspase-1 cleavage in RB51-infected BMDM in absence or presence of 4m8c. Immunoblots are representative of nR 3 independent experiments performed
and imaged in parallel with identical parameters using a Li-Cor Odyssey imaging system.
(C) IL-1b ELISA analysis of supernatants from RB51-infected BMDM treated with or without TUDCA (chemical chaperone, 300 mM) and 4m8c (IRE1 inhibitor,
50 mM). Error bars represent mean ± SD of nR 3 independent experiments. *** represent p value < 0.0001, n.s. = not significant.
(D) qRT-PCR analysis of IL-1b transcript in RB51-infected BMDM in the absence or presence of 4m8c.
(E) Serum IL-1b in mice treated with 5% DMSO (control, n = 15) or 4m8c (n = 15) and infected with RB51 (i.p., CFU 1 3 108). Data in (E) were pooled from two
independent experiments.
(F) IL-1b ELISA analysis of supernatants from RB51-infected BMDM transfected with non-targeted and Xbp1 siRNA.
(G) IL-1b ELISA analysis of supernatants from RB51-infected BMDM transfected with non-targeted and Txnip siRNA.
(H) CM-H2DCFDAwas used to measure ROS during RB51 infection in presence of 4m8c or Txnip siRNA. Rotenone serves as a positive control for ROS induction.
Inset in (F)–(H) demonstrates silencing efficiency by immunoblot. UNT, TM, and L+A represent untreated, tunicamycin (10 mg/mL, positive control for ER stress
activation) and LPS+ATP (200 ng/mL and 1mM respectively; positive control for inflammasome activation). See also Figure S1.
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Figure 2. ER Stress-Induced Mitochondrial
Dysfunction Drives IL-1b Production
(A) The ROS indicator dye, CM-H2DCFDA, was
used to measure ROS in WT and mCAT BMDM
infected with RB51. Rotenone serves as a positive
control for ROS induction.
(B) IL-1b concentrations in supernatants from
RB51-infected WT and mCAT BMDM.
(C) qPCR analysis of mtDNA release into cytosol
during RB51 BMDM infection.
(D) IL-1b concentrations in RB51-infected BMDM
treated with or without cyclosporin A (CsA, 10 mM).
Error bars in (A)–(D) represent mean ± SD of nR 3
independent experiments. *** represent p value <
0.0001, n.s. = not significant. UNT, TM, and L+A
represent untreated and tunicamycin (10 mg/mL,
positive control for ER stress activation), and
200 ng/mL LPS + 1 mM ATP (positive control for
inflammasome activation). See also Figure S2.damages mitochondria, which leads to activation of the inflam-
masome through an IRE1-dependent mechanism.
NLRP3 Mediates IRE1-Induced Mitochondrial Stress
Independently of the ASC Inflammasome Adaptor
In macrophages infected with virulent B. abortus, both NLRP3
and the cytosolic DNA sensor, AIM2, were required for IL-1b pro-
duction (Gomes et al., 2013). Moreover, the AIM2 inflammasome
can regulate IL-1b production when stimulated by transfected
mtDNA (Nakahira et al., 2011). We first assessed whether AIM2
was required for RB51-induced IL-1b production by measuring
IL-1b from RB51-infected WT and Aim2/ BMDM (Figure S3A).
AIM2 did not contribute to IL-1b production induced by RB51-
mediated ER stress. We then reasoned that NLRP3 would be a
likely sensor to respond to the infection-induced ER stress
signal. We first tested whether IRE1 signaling was required for
Nlrp3 transcription, and found that 4m8C treatment did not alter
infection-induced priming of Nlrp3 transcription (Figure S3B).
Upon activation, NLRP3 can translocate from the ER to the mito-
chondria (Zhou et al., 2011) and is reported to trigger mitochon-
drial dysfunction and IL-1b production in the presence of
oxidized mtDNA (Nakahira et al., 2011; Shimada et al., 2012).
To determine whether NLRP3 was involved in controlling the
release of mitochondrial contents during RB51 infection, we
determined whether NLRP3 was recruited to mitochondria. In
RB51-infected WT BMDM, NLRP3 was recruited to the mito-
chondrial fraction at 4 hr pi, which corresponds with the timing
of cytochrome c andmtDNA release (Figures 3A and 3B and Fig-
ure S3C). NLRP3 recruitment to the mitochondria was abolished
inmCAT transgenic and Txnip-silenced BMDM.Nlrp3/macro-
phages did not release mtDNA nor cytochrome c into the cytosol
upon RB51 infection (Figure 3C and Figure S3D). In addition,
NLRP3 deficiency abolished RB51-induced IL-1b production
(Figure 3D) and caspase-1 cleavage (Figure S3E), but did not
affect overall caspase-1 protein amounts. Since NLRP3 ap-
peared to be a key component of RB51-induced inflammasome454 Immunity 43, 451–462, September 15, 2015 ª2015 Elsevier Inc.activation, we investigated whether ASC
or caspase-1, components of the canon-
ical inflammasome, were also crucial toinducing mitochondrial damage. Asc/ and YVAD-CHO (cas-
pase-1 inhibitor)-treated BMDM were not required for mtDNA
and cytochrome c release into the cytosol upon infection (Fig-
ure 3C and Figure S3F). However, ASC and caspase-1 were still
necessary for IL-1bproduction during RB51 infection (Figure 3D).
The inability to produce IL-1b in YVAD-CHO-treated macro-
phages was not due to decreased bacterial uptake (Figure S3G).
Together, these results show that during RB51-induced inflam-
masome activation, NLRP3 plays a critical role in mediating
release of mitochondrial contents, independently of ASC and
caspase-1.
NLRP3 Drives Mitochondrial Dysfunction through
Caspase-2
Under ER stress conditions, NLRP3 might facilitate release
of mitochondrial contents through the cysteine protease,
caspase-2. During genotoxic stress, caspase-2 can cause mito-
chondrial dysfunction leading to cytochrome c release (Robert-
son et al., 2002). Moreover, caspase-2 is activated by ER stress
or RB51 infection (Chen and He, 2009; Upton et al., 2008; Upton
et al., 2012), and regulates caspase-1 activation (Bronner et al.,
2013; Jesenberger et al., 2000). We reasoned that under condi-
tions of ER stress, NLRP3 might be inducing activation of cas-
pase-2 leading to release of mtDNA and cytochrome c into the
cytosol. We probed lysates from control, 4m8C-treated, and
Ern1-silenced (IRE1 depleted) infected macrophages, for full-
length or cleaved active caspase-2 (Figure 4A and Figure S4A).
IRE1was required for caspase-2 cleavage duringRB51 infection,
but not for caspase-2 cleavage triggered by the genotoxic agent,
etoposide (ET). To determine whether NLRP3 acted upstream or
downstream of caspase-2, C57BL/6, and Nlrp3/ BMDM were
infected with RB51, and lysates probed for cleaved caspase-2
(Figure 4B). Caspase-2 cleavage was nearly absent in infected
Nlrp3/ macrophages, whereas caspase-2 cleavage in Asc/
or caspase-1 inhibitor-treated BMDM was comparable to WT
(Figure S4B). We next assessed caspase-2 mitochondrial
Figure 3. NLRP3 Is Required for an ER Stress-Induced Feed-Forward Loop of Mitochondria Damage
Immunoblot of NLRP3 at the mitochondrial fraction of (A) WT and mCAT BMDM and (B) non-targeted (NT) and Txnip-silenced BMDM.
(C) Quantitative PCR of mtDNA in cytosolic extracts from RB51-infected WT and Nlrp3/, Asc/, and z-YVAD-CHO (caspase-1 inhibitor, 2 mM) treated BMDM.
(D) IL-1b concentrations in RB51-infected WT and Nlrp3/, Asc/, and z-YVAD-CHO (caspase-1 inhibitor, 2 mM) inhibited BMDM. Error bars represent mean ±
SD of nR 3 independent experiments. *, **, and *** represent p values of < 0.05, < 0.001, and < 0.0001 respectively. n.s. = not significant. UNT, TM, and LPS+ATP
represent untreated, tunicamycin (positive control for ER stress induction, 10 mg/mL), and LPS+ATP (positive control for inflammasome activation, 200 ng/mL,
and 1mM) respectively. Immunoblots in (A) and (B) are representative of nR 3 independent experiments that were performed and imaged in parallel with identical
parameters using a Li-Cor Odyssey imaging system. See also Figure S3.recruitment and its role in mitochondrial damage. During RB51
infection, caspase-2 was recruited to mitochondria, in an IRE1-
and NLRP3-dependent matter (Figures 4C and 4D). Infected
Casp2/ BMDM released less mtDNA and cytochrome c into
the cytosol (Figures 4E and S4C). Moreover, caspase-2 defi-
ciency abolished IL-1b production and caspase-1 activation
without affecting bacterial uptake (Figure 4F and Figures S4D
and E). AlthoughCasp2/ deficient BMDMwere comparably in-
fected toWT, it is possible that theywere deficient in transcription
of Nlrp3 or Il1b. We performed quantitative RT-PCR analysis to
measureNlrp3and Il1b transcript inWTandCasp2/BMDM. In-
fected Casp2/ BMDM produced similar amounts of Nlrp3 and
Il1b transcript asWTBMDM (Figure 4GandFigureS4F), suggest-
ing that the defect in IL-1b production is not in priming but in acti-
vating the inflammasome. Similar to our in vitro data, Casp2/
mice infected with RB51 exhibited low concentrations of serum
IL-1b and higher bacterial burden (Figure 4H). These data sug-
gest that during infection, NLRP3canmediate ERstress-induced
mitochondrial damage and inflammasome activation by a cas-
pase-2-dependent mechanism.
NLRP3 andCaspase-2 InduceMitochondrial Damage via
the Pore-Activating Factor Bid
We aimed to elucidate themechanism by which NLRP3 and cas-
pase-2 could regulate mitochondrial dysfunction. NLRP3 and
caspase-2 could lead to truncation and activation of Bid, which
damages mitochondria by licensing pore formation of Bax, a
pro-apoptotic factor of the Bcl-2 family (Korsmeyer et al.,
2000). To determine whether Bid was involved in ER stress-
induced mitochondrial damage, we infected 4m8C-treated or
Ern1-silenced (IRE1-depleted) macrophages with RB51, andImprobed for the presence of tBid, using etoposide as a positive
control. Total Bid amounts remained constant under all condi-
tions, but Bid truncation was diminished in 4m8C-treated and
Ern1-silenced macrophages (Figure 5A and Figure S5A),
possibly implicating Bid in ER stress-induced mitochondrial
dysfunction. ET induces mitochondrial dysfunction but does
not induce ER stress (Hitomi et al., 2004; Wang et al., 1998).
Therefore, it was not surprising to see that IRE1 inhibition had
no effect on Bid truncation in ET-treated BMDM. To elucidate
the role of NLRP3 and caspase-2 in this process, we infected
C57BL/6, Nlrp3/, and Casp2/ BMDM with RB51, and the
status of Bid was assessed by immunoblot. Bid truncation
markedly decreased in the absence of NLRP3 and caspase-2
(Figure 5B and Figure S5B). Infected Bid/ BMDM released
less mtDNA into the cytosol than WT controls, confirming that
Bid is required for mitochondrial damage, even though Bid-defi-
ciency did not affect bacterial uptake (Figures 5C and S5C).
Bid/ BMDM infected with RB51 also exhibited diminished
secretion of IL-1b and caspase-1 cleavage (Figures 5D and
5E). Consistent with our in vitro results, RB51-infected Bid/
mice showed a decrease in serum IL-1b, as well as an increase
in bacterial burden in the spleen, compared to wild-type controls
(Figure 5F and Figure S5D). Thus, during RB51 infection, NLRP3
and caspase-2 trigger mitochondrial damage through Bid, lead-
ing to inflammasome activation.
NLRP3 and Caspase-2 Are Required for Inflammasome
Activation in Response to Chemical ER Stress
Our data thus far identified the IRE1-NLRP3-caspase-2-Bid axis
as a mechanism for relaying infection-induced ER stress signals
to the mitochondria, leading to inflammasome activation. Wemunity 43, 451–462, September 15, 2015 ª2015 Elsevier Inc. 455
Figure 4. NLRP3 and Caspase-2 Are Required for ER Stress-Induced Inflammasome Activation
Immunoblot analysis of caspase-2 in (A) with or without 4m8c (IRE1 inhibitor, 50 mM) and (B) RB51-infected WT and Nlrp3/ BMDM. Immunoblot analysis of
caspase-2 in the mitochondrial fraction (C) with or without 4m8c (IRE1 inhibitor, 50 mM) and (D) RB51-infected WT and Nlrp3/ BMDM – ETǂ identifies duplicate
lanes of the same sample.
(E and F) qRT-PCR analysis of mtDNA in cytosolic fractions of infectedWT and Casp2/ BMDM (E). IL-1b concentrations in (F) WT andCasp2/ RB51-infected
(i.p., CFU 1 3 108) BMDM.
(G) qRT-PCR analysis of Il1b transcript in WT and Casp2/ RB51-infected BMDM.
(H) Serum IL-1b serum by ELISA in WT (n = 15) and Casp2/ mice (n = 15). Data in (H) were pooled from two independent experiments. Error bars represent
mean ± SD of nR 3 independent experiments. *, **, and *** represent p values of < 0.05, < 0.001, and < 0.0001 respectively. n.s. = not significant. UNT, ET, TM,
and L+A represent untreated, etoposide (positive control for caspase-2 activation and Bid truncation, 25 mM), tunicamycin (positive control for ER stress
induction, 10 mg/mL), and LPS+ATP (positive control for inflammasome activation, 200 ng/mL and 1mM respectively). Immunoblots in (A)–(D) are representative
of nR 3 independent experiments that were performed and imaged in parallel with identical parameters using a Li-Cor Odyssey imaging system. Full-length
caspase-2 and TOM20 (mitochondrial specific outer membrane protein) serve as loading controls. See also Figure S4.considered the possibility that this pathway might be important
for infection-induced inflammasome activation, but not in the
general ER stress response. We therefore tested whether IRE1,
NLRP3, caspase-2, and Bid were required for inflammasome
activation in response to thapsigargin (TG), tunicamycin (TM),
and brefeldin A (BFA), three chemical inducers that cause ER
stress by distinct mechanisms. Treatment of WT BMDM with
TG, TM, or BFA resulted in robust caspase-1 cleavage but low
IL-1b production, suggesting that minimal priming was occurring
during TG, TM, and BFA treatment in contrast to LPS+ATP
(Figures 6A and 6B). Since both priming to stimulate Il1b tran-456 Immunity 43, 451–462, September 15, 2015 ª2015 Elsevier Inc.scription and inflammasome activation are required for IL-1b
secretion (Schroder and Tschopp, 2010), we assessed proIL-
1b production by immunoblot and found that TM and BFA
induced weak proIL-1b production whereas TG did not trigger
any detectable proIL-1b production (Figure S6A). Thus, ER
stress is a weak inducer of the first signal (priming) that regulates
transcription of Il1b, but can act as a second signal for inflamma-
some activation. Consistent with our infection model, inhibition
of IRE1 abrogated TM- or TG-induced caspase-1 cleavage
(Figure 6B). Although BFA did trigger IRE1 activation as
measured by Xbp1 splicing (Figure S6B), IRE1 was not required
Figure 5. NLRP3 Controls Mitochondrial Dysfunction by a Bid-Dependent Mechanism
Bid truncation in RB51-infected (A) with or without 4m8c (IRE1 inhibitor, 50 mM) and (B) WT and Nlrp3/ BMDM – ETǂ identifies duplicate lanes of the same
sample.
(C) Quantitative PCR of mtDNA in cytosolic extracts from RB51-infected WT and Bid/ BMDM.
(D) ELISA of IL-1b in supernatants from RB51-infected WT and Bid/ BMDM.
(E) Immunoblot analysis of caspase-1 in WT and Bid/ BMDM infected with RB51.
(F) Serum IL-1b inWT (n = 29) andBid/ (n = 30) RB51-infected (i.p. CFU 13 108)mice. The data in (F) were pooled from two independent experiments. Error bars
represent mean ± SD of nR 3 independent experiments. * and *** represent p values of < 0.05 and < 0.0001, respectively. n.s., not significant. UNT, ET, TM, and
L+A represent untreated, etoposide (positive control for Bid truncation, 25 mM), tunicamycin (positive control for ER stress induction, 10 mg/mL), and LPS+ATP
(positive control for inflammasome activation, 200 ng/mL, and 1 mM) respectively. Immunoblots in (A), (B), and (E) are representative of n R 3 independent
experiments that were performed and imaged in parallel with identical parameters using a Li-Cor Odyssey imaging system. Full length (FL) caspase-1 and Bid
serve as loading controls. See also Figure S5.for BFA-induced inflammasome activation as previously re-
ported by Tschopp and colleagues (Menu et al., 2012), perhaps
due to more extensive perturbations in vesicular trafficking
induced by BFA, compared to TM or TG, which act predomi-
nantly on the ER. In TM and TG-treated BMDM deficient in
NLRP3, caspase-2, or Bid, caspase-1 cleavage was virtually ab-
sent (Figures 6C–6E). Although caspase-2 and Bid were critical
for chemical ER stress-induced inflammasome activation,
neither was required for inflammasome activation by LPS+ATP
(Figures 6D and 6E). In total, our data support the IRE1-
NLRP3-caspase2-Bid axis as a key mechanism by which
ER stress drives mitochondrial damage and inflammasome
activation.ImDISCUSSION
ER stress is increasingly implicated in human disease, including
infection, Alzheimer’s disease, and diabetes (Wang and Kauf-
man, 2012). More recent studies have demonstrated a connec-
tion between ER stress and the inflammasome, although the
mechanisms that control signaling have not been fully elucidated
(Lerner et al., 2012; Menu et al., 2012; Oslowski et al., 2012). Our
results have revealed that activation of the IRE1 ER stress sensor
leads to NLRP3-mediated crosstalk between ER and mitochon-
dria, resulting in release of mitochondrial contents through acti-
vation of the caspase-2-Bid signaling axis. Notably, the require-
ment of NLRP3 in ER stress-induced mitochondrial damage wasmunity 43, 451–462, September 15, 2015 ª2015 Elsevier Inc. 457
Figure 6. NLRP3 and Caspase-2 Are Required for Caspase-1 Activa-
tion during General ER Stress
(A) ELISA analysis of IL-1b in supernatants fromBMDM treatedwith 200 ng/mL
LPS and 1mM ATP, positive control for inflammasome activation), or the ER
stressors BFA (brefeldin A, 20 mM), TM (tunicamycin, 10 mg/mL), and TG
(thapsigargin, 10 mM). Error bars represent mean ± SD of nR 3 independent
experiments. ** and *** represent p values of < 0.001 and < 0.0001 respectively.
n.s., not significant.
(B–E) Immunoblot analysis of caspase-1 in (B) BMDM in the absence or
presence of 4m8c (IRE1 inhibitor, 50 mM), (C) WT and Nlrp3/ BMDM – L+Aǂ
identifies duplicate lanes of the same sample, (D) WT and Casp2/ BMDM,
and (E) WT and Bid/ BMDM. Immunoblots in (B)–(E) are representative of n
R 3 independent experiments that were performed and imaged in parallel with
identical parameters using a Li-Cor Odyssey imaging system. Full-length (FL)
caspase-1 serves as a loading control. See also Figure S6.independent of ASC and caspase-1, suggesting that this is not a
function of the canonical NLRP3 inflammasome. Our data place
NLRP3 upstream of caspase-2 in the ER-mitochondrial signaling
pathway and provide a mechanism by which NLRP3 can facili-
tate mitochondrial damage to activate the inflammasome.
Whether NLRP3 or additional inflammasome regulators act as
downstream sensors of mitochondrial damage in ER stress con-
ditions remains to be determined.
The role of mitochondria in activating inflammasomes has
been somewhat controversial. Previously, K+ efflux was pro-
posed as the common mechanism by which diverse stresses458 Immunity 43, 451–462, September 15, 2015 ª2015 Elsevier Inc.that increase membrane permeability, e.g., bacterial toxins or
LPS+ATP, activate the NLRP3 inflammasome without requiring
mitochondrial damage (Allam et al., 2014; Mun˜oz-Planillo et al.,
2013). Other studies have reported that mitochondrial damage
is critical for inflammasome activation by LPS+ATP or by cyto-
solic DNA (Nakahira et al., 2011; Shimada et al., 2012). Further
increasing the complexity of cellular stress signaling, ROS
generated by NADPH oxidase and mitochondrial ROS might
stimulate the inflammasome by different pathways (Martinon,
2010; Wynosky-Dolfi et al., 2014). In the conditions we used,
NLRP3-dependent inflammasome activation by LPS+ATP was
essentially independent of IRE1, caspase-2, Bid, or mitochon-
drial content release. However, ER stress-induced inflamma-
some activation required mitochondrial damage. To reconcile
our results with previously published reports, we speculate that
NLRP3-dependent oligomerization, necessary for inflamma-
some activation, might exhibit distinct signaling requirements
depending on the type or magnitude of stress. A stress that ini-
tiates strong K+ efflux, such as pore formation by bacterial toxins
or pannexin-1 might allow cytosolic NLRP3 oligomerization,
without mitochondrial damage and would therefore not be
blocked by cyclosporin A (Kanneganti et al., 2007; Pelegrin
and Surprenant, 2006). Stress that triggers weaker K+ efflux
might be more dependent on mitochondrial danger signals in
order for NLRP3 to use the mitochondria as a platform for oligo-
merization. Thus, both quality and quantity of a given stress
inducer (i.e., infection, chemical stressors, LPS+ATP) might
define the critical circuits that are integrated to generate inflam-
matory output. NLRP3 has previously been shown to bind the
mitochondrial phospholipid, cardiolipin, which is exposed on
the cytosolic face of mitochondria upon oxidation (Iyer et al.,
2013; Korytowski et al., 2011). Cardiolipin-enriched domains
have been proposed to act as signaling platforms on the mito-
chondria, somewhat analogous to the manner in which choles-
terol-enriched microdomains act as signaling platforms in the
plasma membrane (Schug and Gottlieb, 2009). Notably, proto-
col-specific conditions might be critical in defining the reliance
of inflammasome activation on K+ efflux versus mitochondrial
damage (Horng, 2014; Nakahira et al., 2011; Shimada et al.,
2012). In fact, we found that differing times and concentrations
of LPS+ATP treatments resulted in substantially different
amounts of mtDNA release, perhaps providing an explanation
for why conflicting results have been reported for the reliance
of LPS+ATP on mitochondrial damage. The molecular context
of cellular stress will likely be critical in defining key principles
that govern NLRP3 inflammasome activation.
Microbial infection imposes complex stress conditions upon
infected cells that are not fully defined for most microbes, but
might include K+ efflux, nutrient deprivation, cytoskeletal pertur-
bations, and ROSgeneration. Microbes ormicrobial ligands acti-
vate IRE1 through TLR signaling (Martinon et al., 2010), and
in vivo data clearly show that XBP1, a component of the IRE1
signaling pathway, and NLRP3 can mediate resistance to micro-
bial infection (Martinon et al., 2010; von Moltke et al., 2013).
These observations are consistent with the idea that activation
of ER stress machinery influences the outcome of infection by
tuning inflammatory responses. Importantly, a recent study
demonstrated that IRE1 is required for optimal secretion of
pro-inflammatory cytokines, including IL-1b, in a mouse model
of inflammatory arthritis (Qiu et al., 2013). Cellular stress in the
form of ER perturbation and mitochondrial dysfunction may pro-
vide critical contextual danger signals that together withmicrobi-
al ligands provoke robust immunity. Because ER stress and
mitochondrial dysfunction are also associated with type 2 dia-
betes, obesity, Crohn’s disease, and cancer (Escames et al.,
2012; Garg et al., 2012), it will be of interest to determine whether
theNLRP3-caspase-2 regulatory axis ismore broadly involved in
sterile inflammatory diseases.
NLRP3 has emerged as a critical regulator of the inflamma-
some in response to ER stress and IRE1 activation. How IRE1
leads to NLRP3-dependent stimulation of caspase-2 is still
unclear. NLRP3 binds to the signaling adaptor, TXNIP, whose
translation is controlled by activated IRE1 (Lerner et al., 2012;
Oslowski et al., 2012; Zhou et al., 2010), suggesting that interac-
tion as a possible interface that might lead to recruitment and
cleavage of caspase-2. Alternatively, NLRP3 might interact
with an accessory protein similar to ASC that recruits caspase-2
through its CARD domain. IRE1 itself is reported to modulate
caspase-2 total protein amounts by controlling degradation of
regulatory microRNAs in BFA, TG, or TM-treated murine embry-
onic fibroblasts (Upton et al., 2012). However, a recent report
indicated that overall caspase-2 amounts do not change in
response to ER stress induced in human leukemia- and lym-
phoma-derived cell lines (Sandow et al., 2014), which is consis-
tent with our data in macrophages showing that caspase-2
cleavage, rather than increased caspase-2 protein, is the key
parameter induced by ER stressors. Our results emphasize the
requirement for NLRP3, caspase-2, and mitochondrial damage
in triggering caspase-1 activation specifically in conditions of
ER stress and lay the groundwork for investigating ER stress
modulation as a therapeutic strategy for diseases of inflamma-
tion and immunity.EXPERIMENTAL PROCEDURES
Mice
Humane animal care at the University of Michigan is provided by the Unit for
Lab Animal Medicine, which is accredited by the American Association for
Accreditation of Laboratory Animal Care and the Department of Health and
Human Services. This study was carried out in strict accordance with the rec-
ommendations in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was approved by the Committee on
the Care and Use of Animals (UCUCA) of the University of Michigan.
BidWT (n = 29),Bid/ (Yin et al., 1999) (n = 30), DMSO treated (n = 15), 4m8c
treated (n = 15), casp2 WT (n = 15), and Casp2/ (n = 15) mice (8 12 weeks)
were injected intraperitoneally (i.p.) with Brucella abortus RB51 vaccine strain
(1 3 108 CFU) in 200 ml of phosphate-buffered saline (PBS). Mice were
matched by sex and age. Mice were treated with DMSO (5% in PBS) or
4m8c (25 mg/kg) daily in 200 ml of PBS. Blood was collected by saphenous
vein on day 1, 1, and 3 days pi. Serum was extracted from blood by centri-
fugation for 3 min at 10,000 rpm and used for assessing IL-1b production by
ELISA. At day 3 pi, spleenswere removed from euthanizedmice, homogenized
in 1 ml 0.2% NP-40, and serial dilutions plated onto Brucella agar plates to
enumerate CFU.
Cell Culture and Infection
BMDM were isolated from WT, Casp2/, Asc/, Nlrp3/, Bid/, and
Aim2/ mice. Casp2/ with corresponding WT were purchased from Jack-
son Laboratories (stock #007899) (Bergeron et al., 1998).Nlrp3/ (Kanneganti
et al., 2006) and Asc/ (Ozo¨ren et al., 2006) were maintained by the Nun˜ez
laboratory. Bid/ (Yin et al., 1999) and corresponding WT mice wereImmaintained by the Yin laboratory. Aim2/ (Rathinam et al., 2010) and corre-
sponding WT mice were maintained by the Fitzgerald laboratory (University
of Massachusetts, Worcester).
Isolated BMDM were differentiated in DMEM (GIBCO) supplemented with
20%heat-inactivatedFBS (Invitrogen), 1%L-glutamine (2mM), 1%sodiumpy-
ruvate (1 mM), 0.1% b-mercaptoethanol (55 mM), and 30% L-929 conditioned
medium. BMDMwere cultured in non-TC treated plates at 37C in 5%CO2, fed
fresh media on day 3, and harvested on day 6. Four million RAW264.7 macro-
phages or BMDM were seeded in 6 well plates 18 hr prior to infection. The
LPS+ATP samples were pretreated with LPS (200 ng/mL) overnight, followed
by treatmentwith 1mMATPasdescribed below. The following day,where indi-
cated, cells were pretreated with 10 mM cyclosporin A, 300 mMTUDCA, 50 mM
4m8c, or 2 mMY-VAD-CHO for 1 hr prior to infection. Untreated and pretreated
cells were infected with RB51 (MOI 200) for 30 min, after which inoculum was
removed and cells were washedwith PBS.Medium containing 50 mg/ml genta-
micinwas added to kill extracellular bacteria. To synchronize infection,we spun
cells at 1200 rpm for 3min after adding inoculum. Cells were treatedwith 25 mM
etoposide, 10 mM thapsigargin, 10 mg/mL tunicamycin, 20 mM brefeldin A, or
1 mM ATP for 4 hr. At the indicated times, cells were lysed in buffer containing
1%NP-40 on ice for 15min and spun at 16,000 x g for 15min to pellet the insol-
uble fraction. Soluble fractionswere used for immunoblot assays. The insoluble
fraction was resuspended in mitochondrial suspension buffer (10 mM TrisHCl
pH6.7, 0.15mMMgCl2, 0.25 sucrose, 1mMPMSF, 1mMDTT) and centrifuged
at 11,0003 g for 15 min at 4C to pellet the isolated mitochondria. Purity of iso-
lated mitochondria was assessed by immunoblotting for compartment-spe-
cific markers: calreticulin (ER), TOM20 (mitochondria), Lamin B1 (nucleus),
and Actin (cytosol).
Bacterial Strains and Reagents
Brucella abortus strain RB51 was obtained from Dr. G. Schurig (Virginia Poly-
technic Institute and State University). Reagents were obtained from the
following vendors: Sigma-Aldrich (cyclosporin A, tunicamycin, etoposide, bre-
feldin A, ATP), Fisher (thapsigargin), Calbiochem (TUDCA), Axon (4m8c), and
SCBT (Y-VAD-CHO). Antibodies were obtained from the following vendors:
SCBT (anti-p-PERK sc-32577; anti-ATF6 sc-22799; anti-caspase-1 sc-514;
anti-TOM20 sc-11415; anti-Lamin-b1 sc-20682), Cell Signaling (anti-PERK
3192S; anti-IRE1 3294S; anti-cytochrome c 4272S; anti-Bid 2003S; anti-Cal-
reticulin 2891), Fisher (anti-NLRP3 MAB7578), BioVision (anti-caspase-2
3027-100), and Thermo Scientific (anti-Actin MS1295P1).
Lentivirus Production and Silencing of Ern1
HEK293T cells were grown in DMEMwith 10% fetal bovine serum (Invitrogen).
Lentivirus particles were produced by transfecting the cells with the TRC
shRNA encoding plasmid (pLKO.1) along with the packaging plasmids
(pVSV-G, pGAG-PAL) obtained from the University of Michigan Vector Core.
The medium was changed after 24 hr, and virus particles collected at 48 hr.
Virus-containing medium was concentrated 10-fold by centrifugation
(24,000 rpm) for 2 hr at 4C. Concentrated virus was used to transduce
RAW264.7 cells seeded in 60 mm dishes. The medium was changed 24 hr
post transduction, and cells were left to grow for an additional 24 hr. Trans-
duced cells were selected with puromycin (4 mg/mL) using vectors containing
sequence from a mouse Ern1-specific shRNA plasmid (Open Biosystems:
antisense sequence 50-TTTCTCTATCAATTCACGAGC-30) or a non-targeted
control shRNA plasmid (Sigma-Aldrich).
Transient Silencing of Txnip and Xbp1
Immortalized BMDM were transfected with specific Dharmacon siGENOME
Txnip siRNA (cat# M-040441-01-0005), Xbp1 (cat.# M-040825-00-0005), or
non-targeted siRNA (cat.# D-001206-13-20) using DharmaFECT4 transfection
reagent according to the manufacturer’s protocol. Silencing efficiency was as-
sessed via immunoblot using anti-TXNIP (cat.# NBP1-54578, Novus Biologi-
cals) and anti-XBP1 (cat.# ab37152, Abcam) antibodies.
ROS Measurements
BMDM were plated in a 96 well plate with black slides and clear bottom. At
designated time points, BMDM were washed with PBS and then incubated
with CM-H2DCFDA (Invitrogen) at a final concentration of 2.5 mM in Ringer
buffer (155 mM NaCl, 5 mM KCl, 1 mM MgCl2 6H2O, 2 mM NaH2PO4 H2O,munity 43, 451–462, September 15, 2015 ª2015 Elsevier Inc. 459
10 mM HEPES, 10 mM glucose). Cell were incubated for 30 min at 37C,
washed 3 times with cold PBS, and incubated for an additional 15 min at
37C in warm medium for recovery. After recovery, cells were washed one
more time with PBS. Florescence was measured at excitation/emission
485nm/525nm.
Immunoblot Assay
Cytosolic extracts were separated by SDS-PAGE, transferred to nitrocellulose
membranes (Millipore), blocked with 5% nonfat dry milk in TBS-0.1%
Tween20 (TBS-T), and incubated overnight at 4C with primary antibodies
specified above. Membranes were washed with TBS-T and incubated with
secondary IRDye 680LT Goat anti-rabbit or IRDye 680LT Goat anti-mouse
(1:20,000) at room temperature for 1 hr. Bands were visualized using the
Li-Cor Odyssey Infrared Imaging System. Immunoblots shown in the figures
are representative of nR 3 independent experiments. All immunoblots shown
within an individual panel were analyzed in parallel with identical parameters
using the Li-Cor System.
Cytokine Analysis
Culture supernatants were collected at indicated time points from macro-
phages infected as described. IL-1b concentrations were determined by sand-
wich ELISA per manufacturer’s instructions (BioLegend). A minimum of three
technical replicates per experiment and three experimental replicates were
analyzed for each condition.
Xbp1 Splicing Assay
Total RNA (2 mg) extracted from samples was prepared using the RNeasy Mini
Kit (QIAGEN) and used for cDNA synthesis. Primers encompassing the spliced
sequences in Xbp1mRNA (F: 50-GAACCAGGAGTTAAGAACACG-30 and R: 50-
AGGCAACAGTGTCAGAGTCC-30) were used for PCRamplificationwithGoTaq
polymerase (Invitrogen), with amplification using 30 cycles at 94C 1 min, 60C
1 min, and 72C 1 min. PCR products were incubated with PstI (Invitrogen) at
37C overnight, and separated by electrophoresis (2.5% agarose gel).
Mitochondrial DNA Release Assay
DNA was isolated from 200 ml of the cytosolic fraction using a DNeasy Blood &
Tissue Kit (QIAGEN). Quantitative PCR was employed to measure mtDNA
using Brilliant II SYBR Green with Low ROX (Agilent Technologies) on a
Stratagene MX300 QPCR System. The copy number of mtDNA encoding
cytochrome c oxidase I was normalized to nuclear DNA encoding 18S ribo-
somal RNA. The following primers were used: cytochrome c oxidase I (F: 50-
GCCCCAGATATAGCATTCCC-30 and R: 50-GTTCATCCTGTTCCTGCTCC-30 )
and 18S rRNA (F: 50-TAGAGGGACAAGTGGCGTTC-30 and R: 50-CGCTG
AGCCAGTCAGTGT-30).
Lactate Dehydrogenase Release Assay
Macrophages were seeded in 96-well plates and infected with RB51 as above.
Supernatants were analyzed for LDH enzyme using the CytoTox-ONE Homo-
geneous Membrane Integrity Assay (Promega) per manufacturer’s instruc-
tions. Percentage LDH release was calculated as 100 X [(Experimental LDH
Release – Culture Medium Background)/(Maximum LDH Release – Culture
Medium Background)].
Statistical Analysis
All p values were generated between identified samples using unpaired two-
tailed Student’s t tests and represent analysis ofR 3 replicates per condition.
Asterisks denote the following p values: *p < 0.05, **p < 0.001, and ***p <
0.0001.
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